Balsalazide

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P80AL8J7ZP. European Medicines Agency schedules Balsalazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06092MIG. Balsalazide generally arises in the molecular formula C17H15N3O6. The term BALSALAZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) BALSALAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule balsalazide under HS 29270000 and SITC 51485. As of Q4 2014, BALSALAZIDE remains the US FDA Preferred Term for this commodity. Balsalazide bears US NLM identifiers UMLS ID C0052940 and NCI Concept Code C65247. SMILES: O=C(NCCC(=O)O)C1CCC(N/N=C2/C=C(C(=O)C=C2)C(=O)O)CC1.